• Elbe, Dean


    Investigator, BC Children's Hospital Clinical
    Pharmacy Specialist, Child and Adolescent Psychiatry, BC Children's Hospital Clinical Instructor, Faculty of Pharmaceutical Sciences, University of British Columbia

    Degrees / Designations
    Primary Area of Research
    Brain, Behaviour & Development
    Secondary Area(s) of Research
    Lab Phone
    Mailing Address

    BC Women`s Hospital and Health Centre,
    Room P4-217, 4500 Oak Street
    Vancouver, BC V6H 3N1

    Affiliate Websites
    Research Areas
    • Addiction 
    • Mental disorders (e.g., Anxiety disorders, ADHD, mood disorders, psychotic disorders)
    • Drug interactions 
    • Drug therapy 
    • Pharmacotherapy

    My research pertains to the development of clinical tools for clinicians and members of the public to obtain factual information about drug interactions between prescription medications and substances of abuse.

    Note: Dr. Elbe only accepts research students from the UBC Faculty of Pharmaceutical Sciences (directed studies).

    Current Projects
    Selected Publications

    Whitney Z, Boyda HN, Procyshyn RM, Elbe D, Black T, Eslami A, Barr AM. (2015). Therapeutic drug levels of second generation antipsychotics in youth: a systematic review. J Child Adolesc Psychopharmacol, 25(3), 234-45. PMID: 25803501

    Elbe D, Barr AM, Honer WG, Procyshyn RM. (2014). Managing ADHD and disruptive behaviour disorders with combination psychostimulant and antipsychotic treatment.  J Psychiatry Neurosci, 39(3), 23-3. PMID: 24758945

    Elbe D, Wicholas L. (2014). Lack of detectable serum levels following topical fluoxetine administration in a child.  J Psychiatry Neurosci, 24(2), 105-6. PMID: 24679176

    Elbe D, Reddy D. (2014). Focus on Guanfacine Extended-release: A Review of its Use in Child and Adolescent Psychiatry. J Can Acad Child Adolesc Psychiatry, 23(1), 48-60. PMID: 24516477

    Procyshyn RM, Su J, Elbe D, Liu AY, Panenka WJ, Davidson J, Honer WG, Barr AM. (2014). Prevalence and patterns of antipsychotic use in youth at the time of admission and discharge from an inpatient psychiatric facility. J Clin Psychopharmacol, 34(1), 17-22. PMID: 24346744

    Linton D, Procyshyn RM, Elbe D, Lee LH, Barr AM. (2013). A retrospective study of antipsychotic drug switching in a pediatric population. BMC, 13, 248. PMID:  24103197

    Samilski JA, Lau TT, Elbe DH, Aulakh AK, Lun EM. (2012). Drug use evaluation of moxifloxacin (avelox) using a hand-held electronic device at a Canadian teaching hospital. PT., 37(5), 291-9. PMID: 22876087

    Reebye PN, Elbe D. (2012). Review: evidence on the comparative effectiveness and adverse effects of antipsychotics in young people is limited. Evid Based Ment Health, 15(3), 79. PMID: 22730477

    Elbe D, Lalani Z. (2012). Review of the pharmacotherapy of irritability of autism. J Can Acad Child Adolesc Psychiatry, 21(2), 130-46. PMID: 22548111

    Carandang C, Jabbal R, Macbride A, Elbe D. (2011). A review of escitalopram and citalopram in child and adolescent depression. J Can Acad Child Adolesc Psychiatry,20(4), 315-24. PMID: 22114615

    Ronsley, R., Elbe, D., Smith, D.H., & Garland, E.J. (2010). Do Hospital and Community SSRI Usage Patterns in Children and Adolescents Match the Evidence? J Child Adolesc Psychiatry, 19(3), 218-226. PMID: 20842278

    Elbe, D., Macbride, A., & Reddy, D. (2010). Focus on Lisdexamfetamine: A Review of its use in Child and Adolescent Psychiatry. J Can Acad Child Adolesc Psychiatry, 19(4), 303-14. PMID: 21037922

    Panagiotopoulos, C., Ronsley, R., Elbe, D., Davidson, J., & Smith, D. H. (2010). First do no harm: Promoting an evidence-based approach to atypical antipsychotic use in children and adolescents. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 19(2), 124-137. PMID: 20467549

    Elbe, D., & Savage, R. J. (2009). How does this happen? Part I: mechanisms of adverse drug reactions associated with psychotropic medications. J Can Acad Child Adolesc Psychiatry, 19(1), 40-5. PMID: 20119566

    Reebye, P., & Elbe, D. (2009). The role of pharmacotherapy in the management of self-regulation difficulties in young children. Journal of Canadian Academy of Child and Adolescent Psychiatry, 18(2), 150-156. PMID: 19495438

    Greenaway, M., & Elbe, D. (2009). Focus on aripiprazole: a review of its use in child and adolescent psychiatry. J Can Acad Child Adolesc Psychiatry, 18(3), 250-60. PMID: 19718428

    Elbe D. (2009). Commentary to QTc prolongation associated with atypical antipsychotic use in the treatment of adolescent-onset anorexia nervosa. J Can Acad Child Adolesc Psychiatry, 18(1), 64. PMID: 19270853

    Elbe, D., & Carandang, C.G. (2008). Focus on ziprasidone: a review of its use in child and adolescent psychiatry.  J Can Acad Child Adolesc Psychiatry, 17(4), 220-9. PMID: 19018327

    Elbe DH, Chang SW. (2005). Moxifloxacin-warfarin interaction: a series of five case reports. Ann Pharmacother, 39(2), 361-4. PMID: 15632222

    McCollom RA, Elbe DH, Ritchie AH. (2000). Bupropion-induced serum sickness-like reaction. Ann Pharmacother,  24(4), 47103. PMID: 10772432

    Honours & Awards
    Research Group Members